本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

万春药业

1.92
-0.0300-1.54%
盘后1.920.00000.00%16:04 EDT
成交量:9,180.00
成交额:1.78万
市值:7,740.73万
市盈率:-22.52
高:2.04
开:1.94
低:1.89
收:1.95
数据加载中...
2025/07/03

重要事件披露

Form 8-K - Current report
2025/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/04/11

重要事件披露

Form 8-K - Current report
2025/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/10

SEC问询函

Form CORRESP - Correspondence
2024/07/02

SEC问询函

Form CORRESP - Correspondence
2024/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/15

SEC问询函

Form CORRESP - Correspondence
2023/04/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals